IP Library Granted Patent US 9,580,701
Granted Patent B2
US 9,580,701 · App. 15/238,464 · Granted Feb 28, 2017

CRISPR hybrid DNA/RNA polynucleotides and methods of use

Inventors: Andrew Paul May (San Francisco, CA); Paul Daniel Donohoue (Berkeley, CA)
Assignee: PIONEER HI-BRED INTERNATIONAL, INC.
C12N9/22C12N9/16C12N15/111C12N15/63C12N15/902C12Q1/6827C12Y301/00C12N2310/10C12N2320/51C12N2320/53
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,580,701
App. No.
15/238,464
Granted
Feb 28, 2017
Kind
B2
Abstract

The present disclosure provides DNA-guided CRISPR systems; polynucleotides comprising DNA, RNA and mixtures thereof for use with CRISPR systems; and methods of use involving such polynucleotides and DNA-guided CRISPR systems.

Claims (12)

1. A single polynucleotide comprising:

a targeting region that comprises deoxyribonucleic acid (DNA) or ribonucleic acid (RNA); and

an activating region adjacent to said targeting region that comprises DNA; wherein said activating region comprises a stem loop structure and is capable of binding with a Cpf1.

2. The polynucleotide of claim 1 , wherein the targeting region comprises a mixture of DNA and RNA.

3. The polynucleotide of claim 1 , wherein the targeting region comprises a mixture of DNA and RNA and the activating region comprises a mixture of DNA and RNA.

4. A Class 2 CRISPR system consisting essentially of:

(i) a single polynucleotide comprising (a) a targeting region that comprises deoxyribonucleic acid (DNA) or ribonucleic acid (RNA); and (b) an activating region adjacent to said targeting region that comprises DNA; wherein said activating region comprises a stem loop structure and is capable of binding with a Cpf1; and

(ii) a Cpf1.

5. The Class 2 CRISPR system of claim 4 , wherein said targeting region comprises a mixture of DNA and RNA.

6. The Class 2 CRISPR system of claim 4 , wherein said activating region comprises a mixture of DNA and RNA.

7. The Class 2 CRISPR system of claim 4 , wherein said targeting region comprises a mixture of DNA and RNA and said activating region comprises a mixture of DNA and RNA.

8. The Class 2 CRISPR system of claim 4 , further comprising a donor polynucleotide.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2021
From: PIONEER HI-BRED INTERNATIONAL, INC.
To: CARIBOU BIOSCIENCES, INC.
Reel/Frame 055250/0251 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2016
From: MAY, ANDREW PAUL; DONOHOUE, PAUL DANIEL
To: CARIBOU BIOSCIENCES, INC.
Reel/Frame 040075/0799 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2016
From: CARIBOU BIOSCIENCES, INC.
To: PIONEER HI-BRED INTERNATIONAL, INC.
Reel/Frame 040075/0814 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2016
From: MAY, ANDREW PAUL; DONOHOUE, PAUL DANIEL
To: CARIBOU BIOSCIENCES, INC.
Reel/Frame 040435/0921 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2016
From: CARIBOU BIOSCIENCES, INC.
To: PIONEER HI-BRED INTERNATIONAL, INC.
Reel/Frame 040435/0923 →
Continuity (4)
Division 15008054 · Jan 27, 2016
Provisional Application 62251548 · Nov 5, 2015
Provisional Application 62108931 · Jan 28, 2015
Related Publication 20160362668A1 · Dec 15, 2016